regiocit
bieffe medital s.p.a. - italia - combinatii - sol. pt. hemofiltrare - solutii pentru hemodializa si hemofiltrare solutii pentru hemofiltrare
antithrombin iii baxalta 50 ui/ml
baxter a.g. - austria - antithrombinum iii - pulb+solv. pt. sol. perf. - 50ui/ml - antitrombotice grupul heparinei
glucoza 50%
baxter healthcare s.a. - marea britanie - glucoza - conc. pt. sol. perf. - 500g/1000ml
glucoza 50% (glucosio baxter s.p.a. 50%)
bieffe medital s.p.a. - italia - glucoza - sol. perf. - 50% - solutii pentru administrare intravenoasa solutii pentru alimentatie parenterala
brevibloc 10 mg/ml
baxter s.a. - belgia - esmololum - sol. perf. - 10mg/ml - agenti betablocanti betablocante selective
brevibloc 10 mg/ml
baxter s.a. - belgia - esmololum - sol. perf. - 10mg/ml - agenti betablocanti betablocante selective
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doxorubicină clorhidrat - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - agenți antineoplazici - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
advate 1000 ui
baxter sa - belgia - octocog alfa - pulb.+solv. pt. sol. inj. - 1000ui/5ml - vitamina k si alte hemostatice factori ai coagularii sanguine
advate 1500 ui
baxter sa - belgia - octocog alfa - pulb.+solv. pt. sol. inj. - 1500ui/5ml - vitamina k si alte hemostatice factori ai coagularii sanguine
advate 2000 ui
baxter sa - belgia - octocog alfa - pulb.+solv. pt. sol. inj. - 2000ui/5ml - vitamina k si alte hemostatice factori ai coagularii sanguine